Home/Filings/4/0001104659-20-076845
4//SEC Filing

Jafri Hasan 4

Accession 0001104659-20-076845

CIK 0001614067other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 4:01 PM ET

Size

5.4 KB

Accession

0001104659-20-076845

Insider Transaction Report

Form 4
Period: 2020-06-25
Jafri Hasan
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Stock Options

    2020-06-25+80,00080,000 total
    Exercise: $6.16Exp: 2030-06-25Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on the first year anniversary of the Vesting Commencement Date, which is June 15, 2020. Thereafter, 1/48th of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date, subject to the Optionee providing services through each such vesting date (unless otherwise determined by the Company).

Documents

1 file

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1
  • filerCIK 0001815352

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:01 PM ET
Size
5.4 KB